The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public warning over the circulation of falsified Gold Vision Oxytocin injection 10IU in Nigeria.
In a safety alert published on its official website, NAFDAC disclosed that the product carries a forged registration number and was falsely claimed to be manufactured by Anhui Hongye Pharmaceutical Company in China, but marketed locally by Gold Vision Medicals in Enugu.
The agency said the discovery was made during a routine risk-based sampling survey by its Post-Marketing Surveillance Directorate.
Further checks revealed three other falsified medicines, A-tocin injection, Extocin injection, and Claxitodin injection, all allegedly linked to the same source and bearing the same fake registration details.
NAFDAC emphasised that none of these products are listed in its official database, confirming them as falsified.
Oxytocin, a critical medicine used in labour induction, controlling bleeding after childbirth, and aiding breastfeeding, poses life-threatening risks if compromised.
According to NAFDAC, using fake oxytocin injections could result in weak uterine contractions, postpartum haemorrhage, or maternal death.
Poor-quality formulations may also delay urgent interventions, leading to emergencies such as blood transfusions or surgery.
The agency has directed its zonal directors and state coordinators nationwide to intensify market surveillance and withdraw all falsified products from circulation.
NAFDAC urged importers, distributors, healthcare professionals, and the public to remain vigilant and ensure medicines are purchased only from licensed suppliers.
Consumers and health workers have also been advised to report any suspected falsified or substandard products to the nearest NAFDAC office, call 0800-162-3322, or email [email protected]. Reports can also be submitted via the Med-Safety mobile app or through the agency’s website, www.nafdac.gov.ng.